421 related articles for article (PubMed ID: 19173370)
1. Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders.
Erhardt S; Olsson SK; Engberg G
CNS Drugs; 2009; 23(2):91-101. PubMed ID: 19173370
[TBL] [Abstract][Full Text] [Related]
2. Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia.
Olsson SK; Andersson AS; Linderholm KR; Holtze M; Nilsson-Todd LK; Schwieler L; Olsson E; Larsson K; Engberg G; Erhardt S
Int J Neuropsychopharmacol; 2009 May; 12(4):501-12. PubMed ID: 18796185
[TBL] [Abstract][Full Text] [Related]
3. Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: a pharmacological analysis.
Linderholm KR; Andersson A; Olsson S; Olsson E; Snodgrass R; Engberg G; Erhardt S
Neuropharmacology; 2007 Dec; 53(8):918-24. PubMed ID: 17959203
[TBL] [Abstract][Full Text] [Related]
4. The astrocyte-derived alpha7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex.
Wu HQ; Pereira EF; Bruno JP; Pellicciari R; Albuquerque EX; Schwarcz R
J Mol Neurosci; 2010 Jan; 40(1-2):204-10. PubMed ID: 19690987
[TBL] [Abstract][Full Text] [Related]
5. Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid.
Erhardt S; Engberg G
Acta Physiol Scand; 2002 May; 175(1):45-53. PubMed ID: 11982504
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Large Neutral Amino Acid Transporters Suppresses Kynurenic Acid Production Via Inhibition of Kynurenine Uptake in Rodent Brain.
Sekine A; Kuroki Y; Urata T; Mori N; Fukuwatari T
Neurochem Res; 2016 Sep; 41(9):2256-66. PubMed ID: 27161376
[TBL] [Abstract][Full Text] [Related]
7. Exposure to kynurenic acid during adolescence produces memory deficits in adulthood.
Akagbosu CO; Evans GC; Gulick D; Suckow RF; Bucci DJ
Schizophr Bull; 2012 Jun; 38(4):769-78. PubMed ID: 21172906
[TBL] [Abstract][Full Text] [Related]
8. Targeted deletion of the kynurenine aminotransferase ii gene reveals a critical role of endogenous kynurenic acid in the regulation of synaptic transmission via alpha7 nicotinic receptors in the hippocampus.
Alkondon M; Pereira EF; Yu P; Arruda EZ; Almeida LE; Guidetti P; Fawcett WP; Sapko MT; Randall WR; Schwarcz R; Tagle DA; Albuquerque EX
J Neurosci; 2004 May; 24(19):4635-48. PubMed ID: 15140935
[TBL] [Abstract][Full Text] [Related]
9. A High-performance Liquid Chromatography Measurement of Kynurenine and Kynurenic Acid: Relating Biochemistry to Cognition and Sleep in Rats.
Baratta AM; Viechweg SS; Mong JA; Pocivavsek A
J Vis Exp; 2018 Aug; (138):. PubMed ID: 30176006
[TBL] [Abstract][Full Text] [Related]
10. Endogenous kynurenic acid regulates extracellular GABA levels in the rat prefrontal cortex.
Beggiato S; Tanganelli S; Fuxe K; Antonelli T; Schwarcz R; Ferraro L
Neuropharmacology; 2014 Jul; 82():11-8. PubMed ID: 24607890
[TBL] [Abstract][Full Text] [Related]
11. Ischemic Stroke and Kynurenines: Medicinal Chemistry Aspects.
Hertelendy P; Toldi J; Fülöp F; Vécsei L
Curr Med Chem; 2018; 25(42):5945-5957. PubMed ID: 29532751
[TBL] [Abstract][Full Text] [Related]
12. Effect of Kynurenic Acid on Pupae Viability of Drosophila melanogaster cinnabar and cardinal Eye Color Mutants with Altered Tryptophan-Kynurenine Metabolism.
Navrotskaya V; Wnorowski A; Turski W; Oxenkrug G
Neurotox Res; 2018 Aug; 34(2):324-331. PubMed ID: 29619629
[TBL] [Abstract][Full Text] [Related]
13. Kynurenic acid in neurodegenerative disorders-unique neuroprotection or double-edged sword?
Ostapiuk A; Urbanska EM
CNS Neurosci Ther; 2022 Jan; 28(1):19-35. PubMed ID: 34862742
[TBL] [Abstract][Full Text] [Related]
14. Reduction of brain kynurenic acid improves cognitive function.
Kozak R; Campbell BM; Strick CA; Horner W; Hoffmann WE; Kiss T; Chapin DS; McGinnis D; Abbott AL; Roberts BM; Fonseca K; Guanowsky V; Young DA; Seymour PA; Dounay A; Hajos M; Williams GV; Castner SA
J Neurosci; 2014 Aug; 34(32):10592-602. PubMed ID: 25100593
[TBL] [Abstract][Full Text] [Related]
15. In situ produced 7-chlorokynurenate provides protection against quinolinate- and malonate-induced neurotoxicity in the rat striatum.
Guidetti P; Wu HQ; Schwarcz R
Exp Neurol; 2000 May; 163(1):123-30. PubMed ID: 10785450
[TBL] [Abstract][Full Text] [Related]
16. Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: Implications for Huntington's disease.
Sapko MT; Guidetti P; Yu P; Tagle DA; Pellicciari R; Schwarcz R
Exp Neurol; 2006 Jan; 197(1):31-40. PubMed ID: 16099455
[TBL] [Abstract][Full Text] [Related]
17. Possibility of Amino Acid Treatment to Prevent the Psychiatric Disorders via Modulation of the Production of Tryptophan Metabolite Kynurenic Acid.
Fukuwatari T
Nutrients; 2020 May; 12(5):. PubMed ID: 32414200
[TBL] [Abstract][Full Text] [Related]
18. Enzyme-catalyzed production of the neuroprotective NMDA receptor antagonist 7-chlorokynurenic acid in the rat brain in vivo.
Wu HQ; Salituro FG; Schwarcz R
Eur J Pharmacol; 1997 Jan; 319(1):13-20. PubMed ID: 9030892
[TBL] [Abstract][Full Text] [Related]
19. Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid.
Luchowska E; Luchowski P; Paczek R; Ziembowicz A; Kocki T; Turski WA; Wielosz M; Lazarewicz J; Urbanska EM
J Neurosci Res; 2005 Feb; 79(3):375-82. PubMed ID: 15605380
[TBL] [Abstract][Full Text] [Related]
20. Prenatal Dynamics of Kynurenine Pathway Metabolism in Mice: Focus on Kynurenic Acid.
Goeden N; Notarangelo FM; Pocivavsek A; Beggiato S; Bonnin A; Schwarcz R
Dev Neurosci; 2017; 39(6):519-528. PubMed ID: 29080891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
